Amlodipine and atorvastatin

Mylan Pharmaceuticals Inc.🇺🇸 United States

FDA Page

Effective Date: Oct 15, 2023
Approval ID: 4be76756-4114-4d50-a36c-fd410f6c773d
Products: 8 registered
Version: 16

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use AMLODIPINE AND ATORVASTATIN TABLETS safely and effectively. See full prescribing information for AMLODIPINE AND ATORVASTATIN TABLETS. AMLODIPINE and ATORVASTATIN tablets, for oral use Initial U.S. Approval: 2004

Quick Stats

Total Products8

Labelers2

Label Sections32

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.